Results
1 -
3 of
3Besser Drittlinientherapie als Rechallenge, InFo Onkologie Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review, Journal of Hematology & Oncology Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial, Chinese Journal of Cancer